Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
FF/VI AM vs PM Dosing in Asthma
NCT01287065Phase 2Completed
- Sponsor
- GSK
- Start
- Oct 2010
- Primary completion
- Sep 2011
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 2 trial of fluticasone, vilanterol in asthma, sponsored by GSK. Started Oct 2010; status: completed.
02
Drugs
fluticasonevilanterol
03
Conditions
asthma
Beyond the preview
Go deeper on NCT01287065.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01287065.